Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
carBAMazepine
carBAMazepine
| Drug Name | Form | Strength | Non-Formulary | Restricted | Renal Dosing | REMS | Therapeutic Interchange | Notes |
|---|---|---|---|---|---|---|---|---|
| CarBAMazepine ER | CAPSULE, EXTENDED RELEASE, ORAL | 100 mg, 200 mg, 300 mg | ||||||
| CarBAMazepine | SUSPENSION, ORAL | 100 mg/5 mL | ||||||
| CarBAMazepine | TABLET, CHEWABLE, ORAL | 100 mg | ||||||
| CarBAMazepine ER | TABLET, EXTENDED RELEASE, ORAL | 100 mg, 200 mg , 400 mg | ||||||
| CarBAMazepine | TABLET, ORAL | 200 mg |
Last updated: Sep. 19, 2022
- Black Box Warning: Hematological Risk; Serious Dermatologic Reactions
- Do Not Crush: Extended-release (a) Capsule
- Do Not Crush: Extended-release (b) Tablet
- Hazardous Drugs: Group 2 (NIOSH 2016)
- Hazardous Drugs: Table 2 (NIOSH 2020)
Rhazdrugs: carBAMazepine